Can I read Advances in Tumor Nanotechnology: Theragnostic Implications in Tumors via Targeting Regulated Cell Death on EtoBox?

Advances in Tumor Nanotechnology: Theragnostic Implications in Tumors via Targeting Regulated Cell Death by Jin Li; Xianyanling Yi; Liangren Liu; Xiaohui Wang; Jianzhong Ai is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Advances in Tumor Nanotechnology: Theragnostic Implications in Tumors via Targeting Regulated Cell Death about?

Yet RCD displays as an orchestrated process involving cellular and molecular mechanisms. In addition, with an optional intensive and (or) prolonged interference externally, RCD can be triggered when the one that happens without perturbations is also referred to as programmed cell death (PCD) [1]. More specifically, according to the latest version of the recommendations from the Nomenclature Committee on Cell Death (NCCD) [1], the RCD category mainly contains intrinsic and extrinsic apoptosis, mitochondrial permeability transition-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, netotic cell death, mitotic death, lysosome-dependent cell death (LDCD), autophagydependent cell death, autosis, and immunogenic cell death Xianyanling Yi have contributed equally to this work.

Who reads Advances in Tumor Nanotechnology: Theragnostic Implications in Tumors via Targeting Regulated Cell Death?

Author

Jin Li; Xianyanling Yi; Liangren Liu; Xiaohui Wang; Jianzhong Ai

Publisher

Springer Science and Business Media LLC

Published

2023

Language

EN

Field

Biochemistry, Genetics and Molecular Biology (Life Sciences)